Radiobiological Evaluation of Dosimetric Plans for Stereotactic Radiotherapy for Prostate Cancer According to Fractionation Regimen

Author:

Sukhikh E. S.1,Sheyno I. N.2,Sukhikh L. G.3,Taletskiy A. V.4,Vertinskiy A. V.4,Izhevskiy P. V.2

Affiliation:

1. National Research Tomsk Polytechnic University; Tomsk Regional Oncology Dispensary

2. State Research Center – Burnasyan Federal Medical Biophysical Center, Federal Medical Biological Agency of Russia

3. National Research Tomsk Polytechnic University

4. Tomsk Regional Oncology Dispensary

Abstract

Objective. To determine the most effective irradiation regimen (total dose and dose per fraction) for hypofractionated treatment for prostate carcinomas according the TCP/NTCP radiobiological criteria.Material and methods. Using the tomographic information of five patients with low-risk prostate adenocarcinoma as an example, the authors devised dosimetric radiation therapy plans using the volumetric modulated arc therapy (VMAT) procedure. They considered the range of total doses of 33.5 to 38 Gy administered in 4 and 5 fractions. Based on the equivalent uniform dose concept proposed by A. Niemierko and on the computed differential dose volume histograms, the investigators modeled local tumor control probability (TCP) values, by taking into account the uncertainties of main radiobiological parameters, and estimated normal tissue complication probabilities (NTCP) for the anterior rectal wall as the organ most at risk of irradiation. An effective dosimetric plan was selected according to the UTCP criterion and the probability of complication-free tumor control, i.e. TCP (1 – NTCP).Results. The results of modeling the UTCP criterion show that with a higher total dose, the TCP value increases and so does the NTCP value, therefore the optimal radiation therapy plans are to irradiate with a total dose of 34 Gy over 4 fractions or with a dose of 36–37 Gy over 5 fractions. The difference between the fractionation regimens is that the UTCP value is achieved with a higher TCP value over 4 fractions and with a lower load on the rectal wall over 5 fractions.Conclusion. The choice of a specific fractionation regimen should be determined from the calculated values of differential dose volume histograms for each patient, as well as from radiobiological criteria, such as TCP, NTCP and UTCP.

Publisher

Luchevaya Diagnostika

Subject

General Medicine

Reference20 articles.

1. Lo S.S., Teh B.S., Lu J.J., Schefter T.E. (Eds.). Stereotactic body radiation therapy. Berlin Heidelberg: Springer-Verlag; 2012.

2. Kharchenko V.P., Klepper L.Ya., Panyshin G.А., Sotnikova V.М., Datsenko P.V. Mathematical simulation of Hodgkin lymphoma probability dependence on total dose. Meditsinskaya Fizika (Medical Physics).2005; 4 (28): 28–35 (in Russ.).

3. Brenner D.J. The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin. Radiat. Oncol. 2008; 18 (4): 234–9. DOI: 10.1016/j.semradonc.2008.04.004

4. Li X.A., Alber M., Deasy J.O., Jackson A., Jee K.W., Marks L.B. et al. The use and QA of biologically related models for treatment planning: short report of the TG-166 of the therapy physics committee of the AAPM. Med. Phys. 2012; 39 (3): 1386–409. DOI: 10.1118/1.3685447

5. National Radiotherapy Implementation Group Report. Stereotactic Body Radiotherapy Clinical Review of the Evidence for SBRT. NHS. National Cancer Action Team. Part of the National Cancer Programme. 2010: 13–25. Available at: http://www.academia.edu/978819/National_Radiotherapy_Implementation_Group_Report_Stereotactic_Body_Radiotherapy_Clinical_Review_of_the_Evidence_for_SBRT (accessed October 14, 2019).

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3